Katrin Meissl - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Katrin Meissl

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Cellular and Molecular Life Sciences : CMLS|March 2, 2025

Cell-type-specific requirement for TYK2 in murine immune cells under steady state and challenged conditionsAnzhelika Karjalainen, Agnieszka Witalisz-Siepracka, Michaela Prchal-Murphy, et al.

Haematologica|January 13, 2022

Oncogenic TYK2 P760L kinase is effectively targeted by combinatorial TYK2, mTOR and CDK4/6 kinase blockadeKatharina Woess, Sabine Macho-Maschler, Dorette S Van Ingen Schenau, et al.

Nature Immunology|April 24, 2024

JAK-STAT signaling maintains homeostasis in T cells and macrophagesNikolaus Fortelny, Matthias Farlik, Victoria Fife, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Cellular and Molecular Life Sciences : CMLS|March 2, 2025

Cell-type-specific requirement for TYK2 in murine immune cells under steady state and challenged conditionsAnzhelika Karjalainen, Agnieszka Witalisz-Siepracka, Michaela Prchal-Murphy, et al.

Haematologica|January 13, 2022

Oncogenic TYK2 P760L kinase is effectively targeted by combinatorial TYK2, mTOR and CDK4/6 kinase blockadeKatharina Woess, Sabine Macho-Maschler, Dorette S Van Ingen Schenau, et al.

Nature Immunology|April 24, 2024

JAK-STAT signaling maintains homeostasis in T cells and macrophagesNikolaus Fortelny, Matthias Farlik, Victoria Fife, et al.

Pageof 3